EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, OraSure Technologies's Enterprise Value is $39.1 Mil.
OraSure Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $64.0 Mil. Therefore, OraSure Technologies's EV-to-FCF for today is 0.61.
The historical rank and industry rank for OraSure Technologies's EV-to-FCF or its related term are showing as below:
OSUR'
s EV-to-FCF Range Over the Past 10 Years
Min: -101.38 Med: 13.72 Max: 3626.05
Current: 0.61
During the past 13 years, the highest EV-to-FCF of OraSure Technologies was 3626.05. The lowest was -101.38. And the median was 13.72.
OSUR's EV-to-FCF is ranked better than 94.39% of 374
companies
in the Medical Devices & Instruments industry
Industry Median: 28.73
vs OSUR: 0.61
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The historical data trend for OraSure Technologies's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of OraSure Technologies's EV-to-FCF
For the Medical Instruments & Supplies subindustry, OraSure Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OraSure Technologies's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where OraSure Technologies's EV-to-FCF falls into.
OraSure Technologies's current Enterprise Value is $39.1 Mil.
OraSure Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $64.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
OraSure Technologies's PE Ratio (TTM) for today is calculated as:
OraSure Technologies's share price for today is $4.08.
OraSure Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.150.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
OraSure Technologies EV-to-FCF Related Terms
Thank you for viewing the detailed overview of OraSure Technologies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSUR has been successfully added to your 